Titan Medical announced today that it entered into a definitive amalgamation agreement to combine with Conavi Medical. The companies aim to combine in an all-stock transaction, focusing on commercializing Conavi’s Novasight Hybrid system. Conavi designed Novasight Hybrid to guide common minimally invasive coronary procedures. This merger comes after more than a year of uncertainty around […]
Mergers & Acquisitions
FTC reportedly may scrutinize Boston Scientific’s Axonics deal
Bloomberg reports that the U.S. Federal Trade Commission (FTC) may look into the $3.7 billion acquisition of Axonics (Nasdaq:AXNX) by Boston Scientific . A new Axonics regulatory filing with the SEC discloses that the companies refiled their Hart Scott Rodino (HSR) Act notification to the FTC on March 4 — a move that companies sometimes […]
Haemonetics agrees to acquire esophagus-protecting device maker Attune Medical
Haemonetics announced today that it entered into an agreement to acquire Attune Medical. Boston-based Haemonetics agreed to buy Attune for an upfront cash payment of $160 million. The deal also includes additional contingent consideration based on sales growth in the three years following the consummation of the acquisition. These additional payments also hinge on other […]
Baxter in talks over Kidney Care sale, expects separation later this year
Baxter today shared an update on the planned separation of its Kidney Care business as it looks at a potential sale instead of a spinoff. In January 2023, Baxter announced plans to spin its renal care and acute therapies units into an independent, publicly traded company. It said at the time that it expected the […]
Boston Scientific prices €2B offering to finance Axonics buy
Boston Scientific announced that it priced an offering worth nearly $2.2 billion (€2 billion) in senior notes. American Medical Systems Europe B.V., Boston Scientific’s wholly-owned finance subsidiary, priced the public offering. It includes €750,000,000 aggregate principal amount of 3.375% notes due in 2029 and €1,250,000,000 aggregate principal amount of 3.500% notes due in 2032. Notes […]
DarioHealth acquires digital health company Twill, prices $22.4M offering
DarioHealth (Nasdaq:DRIO) announced today that it acquired digital-led care leader Twill and priced a $22.4 million private placement. New York-based DarioHealth says the acquisition enables it to create a comprehensive digital platform for chronic conditions. This offering would span a wide spectrum of health and wellbeing needs, from emotional health to chronic conditions. The company […]
AngioDynamics sells PICC and Midline portfolios for $45M, discontinues sales of radiofrequency ablation devices
AngioDynamics recently announced the sale of its PICC and Midline product portfolios to Spectrum Vascular for up to $45 million in cash. The company PICC, Midline and tip location products contributed approximately $43.5 million in annual sales during AngioDynamics’ fiscal year 2023. The transaction consists of $34.5 million paid at closing, an earnout related to […]
Ablation tech developer Adagio Medical to go public in SPAC deal
Arya Sciences Acquisition Corp IV agreed to a business combination with Adagio Medical, taking the cardiac ablation company public. Upon the closing of the transaction, Adagio is set to become a subsidiary of Aja Holdco, still operating under its existing management team and under the name “Adagio Medical.” Arya expects to list the combined company’s […]
Zeda acquires The Orthopedic Implant Company
Zeda announced today that it agreed to acquire The Orthopaedic Implant Company (OIC) for an undisclosed amount. San Francisco-based Zeda says the acquisition marks a “significant leap forward” in strengthening its commitment to “revolutionizing manufacturing and distribution of medical devices globally.” OIC delivers high-quality, cost-effective orthopedic devices, Zeda said in a news release. The company […]
ReWalk Robotics looks to the future following Lifeward rebrand
On Jan. 29, ReWalk Robotics announced a rebrand to “Lifeward.” The rebrand had, in many ways, been in the works for about six months. Really, though, Lifeward CEO Larry Jasinski started formulating this plan a few years ago. All it needed was a few key ingredients to propel the physical rehabilitation and recovery company forward. […]
BCI developer Synchron buys stake in thin film maker Acquandas
Synchron, a developer of brain-computer interface (BCI) technology, today announced the acquisition of an equity stake in Acquandas. Acquandas, a German-based company, specializes in high-precision components for healthcare and other industries. The company bases its metallic components on state-of-the-art microsystem technology processes. It fabricates thin film components for applications in medical devices, including micro-patterned nitinol […]